CLIFFORD IRIELE: Open Payments
NPI 1518124718 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$235 in 8 payments from 4 companies in 2025. Trend: 2023 $389 · 2024 $78 · 2025 $235
Food & beverage: $235
| Company | Payments | Amount |
|---|---|---|
| Luye Pharma (USA) Ltd. | 3 | $82 |
| Teva Pharmaceuticals USA, Inc. | 2 | $66 |
| Janssen Pharmaceuticals, Inc | 2 | $60 |
| E.R. Squibb & Sons, L.L.C. | 1 | $26 |
Products named: ERZOFRI EXTENDED-RELEASE, UZEDY, INVEGA SUSTENNA, COBENFY.
Industry payments across CA — which companies pay providers there.
